Steroid withdrawal in pediatric kidney transplant allows better growth, lipids and body composition: a randomized

Veronica Mericq1, Paulina Salas, Viola Pinto

  • 1Institute of Maternal and Child Research, University of Chile, Santiago, Chile.

Insights

Early steroid withdrawal in pediatric kidney transplant patients significantly improves growth and body composition. This approach enhances lipid profiles and, in prepubertal children, suggests better insulin sensitivity.

Area of Science:

  • Pediatric Nephrology
  • Immunosuppression Therapy
  • Transplantation Medicine

Background:

  • Glucocorticoid immunosuppressants hinder growth in pediatric kidney transplant recipients.
  • Optimizing post-transplant outcomes requires addressing growth and metabolic complications.

Purpose of the Study:

  • To evaluate the impact of early steroid withdrawal (SW) on growth, insulin sensitivity (IS), and body composition (BC) in pediatric kidney transplant patients.
  • To compare outcomes between early SW and standard steroid treatment.

Main Methods:

  • Prospective, randomized, multicenter study involving pediatric kidney transplant recipients.
  • Assessed Insulin-like Growth Factor (IGF)-I, IGF-binding protein 3 (IGFBP3), IS, and BC (DEXA/pQCT) at baseline and 12 months post-transplant.

Main Results:

  • Early SW group showed significantly greater height SDS increase compared to steroid control (SC) group (+1.2 vs. +0.60).
  • SW patients exhibited improved lipid profiles (lower cholesterol, higher HDL) and reduced trunk fat.
  • Prepubertal SW recipients demonstrated lower glycemia, triglycerides, and improved lean mass and insulin sensitivity (lower TyG index).

Conclusions:

  • Early steroid withdrawal enhances longitudinal growth, lipid profiles, and body composition in pediatric kidney transplant recipients.
  • SW may improve insulin sensitivity in prepubertal recipients, indicated by a reduced triglycerides/glycemia index.
Abstract

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...